Home > News > APP and ABI Complete Merger
April 19th, 2006
APP and ABI Complete Merger
Abstract:
American Pharmaceutical Partners, Inc. (NASDAQ:APPX) (APP), a specialty injectable pharmaceutical company, and its parent company American BioScience, Inc. (ABI), a biotechnology company, today announced that the merger between the two companies has been completed. The combined company is named Abraxis BioScience, Inc. (Abraxis) and its common stock will trade as of April 19 on the Nasdaq National Market under the new ticker symbol "ABBI."
Source:
pharmalive.com
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||